Global Multiple Sclerosis Therapies Market Research and Upcoming Forecast Report
© 2019 IMARC All Rights Reserved
Author: Elena Anderson, Marketing Manager | Copyright © IMARC Service Pvt Ltd. All Rights Reserved IMARC Group
About IMARC Group
Report Description
International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all sectors and region.The s to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.
Report Description and Highlights Report Description Multiple Sclerosis Therapies Market Outlook 2026:
According to the latest report by IMARC Group, titled "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026," the global multiple sclerosis therapies market size reached US$ 24.4 Billion in 2020. Multiple sclerosis (MS) therapies refer to various drugs and treatments that help modify the course of the disease, speed up recovery from attacks, and manage symptoms in patients. Some commonly used MS therapies include antidepressants, immunosuppressants, physical therapy, muscle relaxants, and oral, infused and injectable medicines. They aid in treating specific MS symptoms, reducing the frequency of relapses, and controlling the heart rate and blood pressure of patients. Presently, there is no cure for MS; however, doctors can determine the most suitable therapies that cause the least side effects and help the patient manage the disease. Request for a PDF sample of this report: https:// www.imarcgroup.com/multiple-sclerosis-therapies-market/requestsample
Report Description and Highlights
Report Description
Global Multiple Sclerosis Therapies Market Trends:
The rising prevalence of relapsing-remitting MS (RRMS) and secondary-progressive MS (SPMS) represents the primary factor driving the global market. Besides this, several initiatives undertaken by government and non-government organizations to spread awareness regarding MS symptoms and available treatment options are catalyzing the market growth. Additionally, the escalating demand for novel potent and rapid-acting drugs is encouraging manufacturers to develop advanced product variants with high efficacy, low dosage requirements and minimal side effects. This, in confluence with the heavy investments by key players in the drug development process, is propelling the market growth. Furthermore, the launch of innovative monoclonal bodies, immunosuppressants, immunomodulators, and interferons to effectively treat MS symptoms is accelerating product adoption rates. Other factors, including recent technological advancements, ongoing research and development (R&D) activities, improving healthcare infrastructure and increasing focus of pharmaceutical companies on pipeline drugs, are creating a favorable market outlook. Looking forward, the market is anticipated to grow at a CAGR of around 5% during the forecast period (2021-2026).
Report Description and Highlights
Report Description Key Market Segmentation: Breakup by Drug:
•Immunomodulators •Immunosuppressants
Breakup by Drug Type: •Biologic Drugs •Small Molecule Drugs
Breakup by Route of Administration: •Oral •Injectable •Intravenous
Breakup by Distribution Channel: •Hospital Pharmacies •Retail Pharmacies •Online Pharmacies
Report Description and Highlights
Report Description Breakup by Region:
•North America •Asia Pacific •Europe •Latin America •Middle East and Africa Note: We are updating our research report 2021-2026. If you want to need latest primary and secondary data with Cost Module, Business Strategy, Distribution Channel, etc
Report Description and Highlights
Report Description Competitive Landscape:
•Abbvie Inc. •Bayer Aktiengesellschaft •Biogen Inc. •Bristol-Myers Squibb Company •F. Hoffmann-La Roche AG (Roche Holding AG) •GlaxoSmithKline Plc •Merck & Co. Inc. •Novartis AG •Sanofi S.A. •Teva Pharmaceutical Industries Ltd. View Report TOC, Figures and Tables: https:// www.imarcgroup.com/multiple-sclerosis-therapies-market
A partial List of
We are the trusted business partners to the
Clients world's leading corporates, governments, and ourPartial ClientsList of institutions
Report Description and Highlights
Report Description
© 2019 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.
A partial List of
We are the trusted business partners to the
of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions
Contact Us
FOR MORE DETAILS Visit us at :
https://www.imarcgroup.com Stay With Us:
TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com